Mauna Kea Technologies | Ownership
Companies that own Mauna Kea Technologies
FORUM Family Office Services GmbH
516,560
2.23%
450,415
5.41%
06/30/2018
Bellevue Asset Management AG
464,583
2%
359,524
0.02%
07/31/2018
Pascal Investment Advisers SA
450,000
1.94%
50,000
0.82%
12/31/2017
La Banque Postale Asset Management SA
76,535
0.33%
0
0%
06/29/2018
Pure Capital SA
62,500
0.27%
35,000
0.16%
06/30/2017
Tocqueville Finance SA
54,823
0.24%
0
0.01%
06/29/2018
Hogep Hoche Gestion Privée SA
54,377
0.24%
-11,765
0.24%
12/29/2017
HSBC Global Asset Management (France) SA
52,075
0.23%
0
0%
12/29/2017
OFI Asset Management SA
50,000
0.22%
50,000
0%
12/29/2017
Gestys SA
50,000
0.22%
-10,000
2.54%
03/23/2018
| Address |
9, rue d'Enghien
Paris Ile-de-France 75010
France
|
|
Employees
|
- |
| Website |
http://www.maunakeatech.com |
| Updated |
07/08/2019 |
| Mauna Kea Technologies SA is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases. The company engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. Its product, Cellvizio, a probe-based Confocal Laser Endomicroscopy system, provides physicians and researchers high resolution cellular views of tissue inside the body. |
